Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Apr 26, 2023 (3 years ago)

DYNAMITE SUPER capsule

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC 6 75799 37602 7.

Recalling firm
Gadget Island, Inc
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0573-2023 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other recalls by Gadget Island, Inc

All 2023 recalls
Class I · High risk

NUX Male Enhancement capsule

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Ongoing Chemical / undeclared Gadget Island, Inc D-0572-2023
Class I · High risk

Pro Power Knight Plus capsule

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Ongoing Chemical / undeclared Gadget Island, Inc D-0571-2023
Class I · High risk

grande X 5800 capsule

Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.

Terminated Chemical / undeclared Gadget Island, Inc D-0106-2018
Class I · High risk

FIFTY SHADES 6000 capsule

Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.

Terminated Chemical / undeclared Gadget Island, Inc D-0105-2018

Other chemical / undeclared recalls from 2023

All chemical / undeclared recalls
Class I · High risk

Americaine

Chemical Contamination: presence of benzene

Completed Chemical / undeclared Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company NDC 63736-378-02 D-0236-2024
Class I · High risk

Magnum XXL 9800

Marketed without an approved NDA/ANDA: Magnum XXL found to contain undeclared active pharmaceutical ingredient (API) - Sildenafil.

Ongoing Chemical / undeclared Meta Herbal D-0206-2024
Class I · High risk

Dr. Ergin's SugarMD

MARKETED WITHOUT AN APPROVED NDA/ANDA: Product found to be tainted with metformin and glyburide

Ongoing Chemical / undeclared Sugarmds LLC D-0138-2024